Latest immunotherapy News | Page 9 | The National Tribune

2 Nov 2023 4:21 pm AEST

Preventing Exhaustion of T Cells

31 Oct 2023 10:48 am AEST

Multi-million dollar boost into child research programs

31 Oct 2023 9:24 am AEST

Dom’s Finding strength in being open about cancer

27 Oct 2023 3:06 pm AEST

Cancer’s sweet Achilles heel

27 Oct 2023 12:12 pm AEST

Clinical trials give Queensland breast cancer patients hope

24 Oct 2023 2:39 pm AEST

Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab

23 Oct 2023 4:09 pm AEST

Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer

22 Oct 2023 5:00 pm AEST

Datopotamab deruxtecan plus Imfinzi demonstrated robust and durable tumour responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA…

20 Oct 2023 10:03 pm AEST

Imfinzi plus chemotherapy more than doubled pathologic complete response rate in resectable early-stage gastric and gastroesophageal junction cancers versus chemotherapy alone

20 Oct 2023 7:37 am AEST

Alice Springs Hospital oncology and cardiology services supporting patients

19 Oct 2023 1:19 pm AEST

Western Australian doctors to explore new frontiers in cancer fight

17 Oct 2023 10:45 am AEST

Research Advisory Board Welcomes Professor Cameron Turtle

14 Oct 2023 12:36 am AEST

Ludwig Institute Board Member Jedd Wolchok elected to National Academy of Medicine

12 Oct 2023 4:15 pm AEST

New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships

11 Oct 2023 4:07 pm AEST

AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMO

11 Oct 2023 1:00 am AEST

Fall allergies: Ragweed and mold are in air

28 Sep 2023 5:00 am AEST

Study shows how brain tumors make certain immune cells turn traitor

28 Sep 2023 12:30 am AEST

Combination therapy promising against ‘cold’ breast cancer tumors

22 Sep 2023 1:33 am AEST

Combination of personalized cancer vaccine and adoptive T cell therapy benefits patients with advanced ovarian cancer

21 Sep 2023 1:30 am AEST

Disrupting a core metabolic process in T cells may improve their therapeutic efficacy

20 Sep 2023 4:03 pm AEST

How do hay fever treatments actually work? And what’s best for my symptoms?

18 Sep 2023 6:24 pm AEST

£½ million funding announced to find new treatment for oesophageal cancer

16 Sep 2023 12:24 am AEST

Enhertu recommended for approval in the EU by CHMP for patients with HER2-mutant advanced non-small cell lung cancer

12 Sep 2023 2:30 pm AEST

Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate

28 Aug 2023 9:51 am AEST

Veronica’s Finding light beyond storm

22 Aug 2023 11:27 am AEST

BCNA welcomes decision to recommend Keytruda for subsidy for early-stage breast cancer

7 Aug 2023 8:39 am AEST

Mater Researcher’s lymphoma studies attract funding boost

4 Aug 2023 5:06 am AEST

Ludwig Lausanne study illuminates a potentially exploitable coordination of gene expression across the tumor microenvironment

2 Aug 2023 10:12 am AEST

Vital boost to blood cancer treatment

2 Aug 2023 1:15 am AEST

Is it Allergies or Something Else?

1 Aug 2023 12:03 pm AEST

Daffodil Day appeal is raising much needed funds

26 Jul 2023 11:12 am AEST

HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement

21 Jul 2023 1:33 pm AEST

World-first clinical trial for blood cancer underway in the Illawarra

17 Jul 2023 8:33 pm AEST

Immune cells in single file

5 Jul 2023 7:03 am AEST

International collaboration to fund breakthrough research to shape the future of precision medicine

27 Jun 2023 12:27 pm AEST

Gaining insight into the potential of cannabis in combating viral infections

13 Jun 2023 9:39 am AEST

Donation allows scientists to explore asbestos treatments

12 Jun 2023 4:36 pm AEST

Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer

8 Jun 2023 2:24 am AEST

Ludwig Cancer Research study shows certain blood pressure drugs could boost the efficacy of cancer immunotherapy

5 Jun 2023 10:15 pm AEST

Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial

3 Jun 2023 10:03 pm AEST

Lynparza and Imfinzi combination reduced risk of disease progression or death by 37% vs. chemotherapy and bevacizumab in patients with advanced ovarian…

3 Jun 2023 1:36 am AEST

Memory killer cells can improve survival for melanoma patients

31 May 2023 5:42 pm AEST

Improving Immune Checkpoint Inhibitors’ Anti-tumor Response and Minimizing Side Effects

31 May 2023 11:39 am AEST

Life Now participant finds mental and physical benefit from exercising during cancer treatment

26 May 2023 10:54 pm AEST

Ludwig Chicago study identifies potentially new strategy for combination radio- and immunotherapy

26 May 2023 4:09 pm AEST

Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy

25 May 2023 4:09 pm AEST

AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023

24 May 2023 1:30 pm AEST